West Pharma Beats Q3, Lifts FY26 EPS Guidance to $9.38-$9.48 and Sales to $3.41B-$3.42B
WST sits 84% above its 52-week low of $223.83.
Summary
West Pharmaceutical beat Q3 expectations with 11.9% organic sales growth and $2.66 adjusted EPS, then raised full-year 2026 guidance to $9.38-$9.48 adjusted EPS on $3.41-$3.42 billion in sales.
Key Events · Earnings and Guidance · WST
-
Q3 Beat With 11.9% Organic Growth
Net sales of $874.5 million rose 8.7% reported and 11.9% organic; adjusted-diluted EPS of $2.66 rose 35.7% year over year.
-
Full-Year Guidance Raised Sharply
FY26 adjusted-diluted EPS guidance lifted to $9.38-$9.48 from $8.85-$9.05, and net sales guidance to $3.41-$3.42 billion from $3.345-$3.380 billion.
-
HVP Components Drive the Mix
HVP Components net sales of $466.7 million grew 19.7% reported and 20.3% organic, reaching 53% of total company net sales.
-
Buybacks and Dividend Increased
The company repurchased $231 million of stock in the quarter ($685 million year to date) and raised the quarterly dividend 18% to $0.26 per share.
Analysis · WST · Industrial Applications And Services
West delivered an 11.9% organic sales quarter and 35.7% adjusted EPS growth, then raised full-year guidance by roughly $0.50 at the EPS midpoint and about $50 million at the sales midpoint. The raise is the story: it tells investors the HVP Components franchise (up 20.3% organic, 53% of sales) is still compounding faster than the base business, and that the May cyber incident did not dent the trajectory. Against a stock trading near its 52-week high, the risk is that expectations were already high, so the size of the beat and raise — not just the direction — is what matters.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, WST was trading at $410.95 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $28.4B. The 52-week trading range was $223.83 to $404.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.